These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33426641)

  • 1. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
    Odi R; Franco V; Perucca E; Bialer M
    Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Basis of Generic Substitution of Antiseizure Medications.
    Elmer S; Reddy DS
    J Pharmacol Exp Ther; 2022 May; 381(2):188-196. PubMed ID: 35241634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations.
    Karalis V; Macheras P; Bialer M
    CNS Drugs; 2014 Jan; 28(1):69-77. PubMed ID: 24092569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.
    Berg M; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Switzer RD; Privitera MD
    JAMA Neurol; 2017 Aug; 74(8):919-926. PubMed ID: 28654954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin.
    Maliepaard M; Banishki N; Gispen-de Wied CC; Teerenstra S; Elferink AJ
    Eur J Clin Pharmacol; 2011 Oct; 67(10):1007-16. PubMed ID: 21494766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
    Le Corre P
    Presse Med; 2010 Feb; 39(2):169-76. PubMed ID: 19932591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.
    Privitera MD; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Berg M
    Lancet Neurol; 2016 Apr; 15(4):365-72. PubMed ID: 26875743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M; Midha KK
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switchability of Gabapentin Formulations: A Randomized Trial to Assess Bioequivalence Between Neurontin and Gabasandoz on the Individual Subject Level.
    Van Lancker G; Van Bortel L; Delafontaine B; Boussery K; Swart E; Chahbouni A; Van Bocxlaer J; Colin P
    Clin Pharmacol Ther; 2019 Jul; 106(1):195-203. PubMed ID: 30636281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing bioequivalence of generic antiepilepsy drugs.
    Krauss GL; Caffo B; Chang YT; Hendrix CW; Chuang K
    Ann Neurol; 2011 Aug; 70(2):221-8. PubMed ID: 21717495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study.
    Fang L; Li Z; Kinjo M; Lomonaco S; Zheng N; Jiang W; Zhao L
    Epilepsia; 2023 Jan; 64(1):152-161. PubMed ID: 36259141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
    Knight R; Wittkowski A; Bromley RL
    Epilepsia; 2021 Aug; 62(8):1765-1779. PubMed ID: 34128227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.
    Pejčić Z; Vučićević K; García-Arieta A; Miljković B
    Br J Clin Pharmacol; 2019 Sep; 85(9):2059-2065. PubMed ID: 31140620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.
    Hammami MM; De Padua SJS; Hussein R; Al Gaai E; Khodr NA; Al-Swayeh R; Alvi SN; Binhashim N
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):78. PubMed ID: 29216899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.